Orexo Future Growth
Future criteria checks 5/6
Orexo is forecast to grow earnings and revenue by 71.3% and 23.1% per annum respectively. EPS is expected to grow by 76.6% per annum. Return on equity is forecast to be -155.1% in 3 years.
Key information
71.3%
Earnings growth rate
76.6%
EPS growth rate
| Pharmaceuticals earnings growth | 19.3% |
| Revenue growth rate | 23.1% |
| Future return on equity | -155.1% |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 994 | -7 | N/A | -33 | 2 |
| 12/31/2023 | 716 | -29 | 84 | -35 | 4 |
| 12/31/2022 | 620 | -87 | 108 | -128 | 4 |
| 9/30/2022 | 612 | -152 | -203 | -188 | N/A |
| 6/30/2022 | 597 | -177 | -241 | -207 | N/A |
| 3/31/2022 | 592 | -216 | -285 | -243 | N/A |
| 12/31/2021 | 565 | -223 | -282 | -229 | N/A |
| 9/30/2021 | 580 | -207 | -239 | -160 | N/A |
| 6/30/2021 | 585 | -240 | -201 | -93 | N/A |
| 3/31/2021 | 621 | -198 | -281 | -79 | N/A |
| 12/31/2020 | 664 | -84 | -173 | 17 | N/A |
| 9/30/2020 | 743 | 4 | -94 | 84 | N/A |
| 6/30/2020 | 824 | 201 | 89 | 231 | N/A |
| 3/31/2020 | 846 | 288 | 248 | 284 | N/A |
| 12/31/2019 | 845 | 219 | 255 | 287 | N/A |
| 9/30/2019 | 834 | 232 | 286 | 302 | N/A |
| 6/30/2019 | 819 | 182 | 192 | 194 | N/A |
| 3/31/2019 | 818 | 178 | 183 | 187 | N/A |
| 12/31/2018 | 783 | 138 | 238 | 242 | N/A |
| 9/30/2018 | 747 | 113 | 144 | 147 | N/A |
| 6/30/2018 | 697 | 79 | 212 | 215 | N/A |
| 3/31/2018 | 656 | 32 | 223 | 225 | N/A |
| 12/31/2017 | 644 | 23 | 145 | 147 | N/A |
| 9/30/2017 | 637 | 19 | 240 | 241 | N/A |
| 6/30/2017 | 653 | 27 | 189 | 191 | N/A |
| 3/31/2017 | 682 | 29 | 149 | 151 | N/A |
| 12/31/2016 | 706 | 29 | 155 | 156 | N/A |
| 9/30/2016 | 752 | -57 | 82 | 84 | N/A |
| 6/30/2016 | 710 | -139 | N/A | -38 | N/A |
| 3/31/2016 | 648 | -229 | N/A | -82 | N/A |
| 12/31/2015 | 646 | -210 | N/A | -109 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ORXs is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: ORXs is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ORXs is expected to become profitable in the next 3 years.
Revenue vs Market: ORXs's revenue (23.1% per year) is forecast to grow faster than the UK market (4% per year).
High Growth Revenue: ORXs's revenue (23.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ORXs is forecast to be unprofitable in 3 years.